Successful prenatal management of two foetuses affected by antibodies against GP.Mur with prenatal genotyping analysis and a literature review.

BACKGROUND GP.Mur belongs to the GP(B-A-B) hybrid glycophorin family, which is the most common hybrid glycophorin in Southeast Asia. Antibodies against GP.Mur may cause a clinically significant haemolytic disease of the foetus and newborn (HDFN) although, so far, not many cases have been reported in mainland China. MATERIALS AND METHODS Two Chinese women with a history of severe hydrops foetalis were seen in our centre. Alloantibody identification and GYP.Mur genotyping analysis were used for prenatal evaluation. Intrauterine transfusion was performed in two pregnancies in case 1. The features of these two women are described and literature-reported cases of HDFN related to antibodies against GP.Mur are summarised. RESULTS The phenotype of both mothers was Mia- Mur-, while the fathers' was Mia+ Mur+ with a heterozygous GYP.Mur hybrid gene as determined by a high-resolution melting method of genotyping. In case 1, the antibodies against GP.Mur were detected in the mother's serum and the cord blood of two foetuses. Fortunately, the latest foetus was successfully saved after intrauterine transfusion. In case 2, hydrops foetalis occurred in the first two pregnancies, but the risk of HDFN was excluded for the third foetus because of the GP.Mur negative phenotype. The literature review showed that 68.8% (11/16) of the reported cases of HDFN related to antibodies against GP.Mur occurred in the Chinese population, and that 37.5% (6/16) of them were cases of severe HDFN. DISCUSSION More cases of severe HDFN caused by antibodies against GP.Mur are presumably undetected as GP.Mur cells are not included in the panel of obligatory screening tests in most Southeast Asian countries including mainland China. The high-resolution melting method for GYP.Mur genotyping and zygosity detection is helpful in prenatal management.

[1]  J. Storry,et al.  Characterization of GYP*Mur and novel GYP*Bun‐like hybrids in Thai blood donors reveals a qualitatively altered s antigen , 2020, Vox sanguinis.

[2]  Xuan Ma,et al.  [Analysis of Screening Results in 501 Newborns with Hemolytic Disease]. , 2019, Zhongguo shi yan xue ye xue za zhi.

[3]  Jiancheng Han,et al.  Isolated premature restriction or closure of foramen ovale in fetuses: Echocardiographic characteristics and outcome , 2018, Echocardiography.

[4]  Yang Zhang,et al.  Genotyping analysis of MNS blood group GP(B‐A‐B) hybrid glycophorins in the Chinese Southern Han population using a high‐resolution melting assay , 2018, Transfusion.

[5]  C. Hyland,et al.  Genotyping for Glycophorin GYP(B-A-B) Hybrid Genes Using a Single Nucleotide Polymorphism-Based Algorithm by Matrix-Assisted Laser Desorption/Ionisation, Time-of-Flight Mass Spectrometry , 2016, Molecular Biotechnology.

[6]  R. Flower,et al.  The distribution of MNS hybrid glycophorins with Mur antigen expression in Chinese donors including identification of a novel GYP.Bun allele , 2016, Vox sanguinis.

[7]  B. Glader,et al.  Anti‐Mur as the most likely cause of mild hemolytic disease of the newborn , 2016, Transfusion.

[8]  B. Veldhuisen,et al.  Comprehensive genotyping for 18 blood group systems using a multiplex ligation‐dependent probe amplification assay shows a high degree of accuracy , 2013, Transfusion.

[9]  Yu-Cheng Chang,et al.  A direct blood polymerase chain reaction approach for the determination of GP.Mur (Mi.III) and other Hil+ Miltenberger glycophorin variants , 2013, Transfusion.

[10]  S. Yu,et al.  A Case of Hemolytic Disease of Newborn due to Anti-JKa , 2012 .

[11]  Damien J Heathcote,et al.  Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? , 2011, Transfusion medicine reviews.

[12]  C. Lin,et al.  First case of haemolytic disease of the newborn due to anti-Mur in Hong Kong. , 2010, Clinical and laboratory haematology.

[13]  M. Reid,et al.  Detection of MNS hybrid molecules in the Thai population using PCR‐SSP technique , 2007, Transfusion medicine.

[14]  A. G. van den Bos,et al.  Haemolytic disease of the newborn caused by anti‐MUT (MNS 35) , 2004, Vox sanguinis.

[15]  J. Chang,et al.  Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan , 2003, Transfusion medicine.

[16]  J. Chang,et al.  Hydrops foetalis caused by anti‐Mur in first pregnancy – a case report , 2002, Transfusion medicine.

[17]  J. Wysocka,et al.  [Cord blood reticulocytes and reticulocyte subtypes in normal and complicated pregnancy]. , 2002, Medycyna wieku rozwojowego.

[18]  F. Klumper,et al.  The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. , 2001, American journal of obstetrics and gynecology.

[19]  S. Blackwell,et al.  Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. , 2000, The New England journal of medicine.

[20]  J. Chang,et al.  Genomic typing of human red cell Miltenberger glycophorins in a Taiwanese population , 2000, Transfusion.

[21]  M. Lin,et al.  The distribution of the MiIII (GP.Mur) phenotype among the population of Taiwan , 1996, Transfusion medicine.

[22]  K. Mak,et al.  A case of hydrops fetalis, probably due to antibodies directed against antigenic determinants of GP.Mur (Miltenberger class III) cells , 1996, Immunohematology.

[23]  M. Lin,et al.  The incidence and significance of anti‐“Mia” in Taiwan , 1994, Transfusion.

[24]  Y. Liew,et al.  The MiIII phenotype among Chinese donors in Hong Kong: immunochemical and serological studies , 1991, Transfusion medicine.

[25]  F. Stratton,et al.  Human Blood Groups , 1951, Nature.